PDF icon Download PDF
Open Access
CC BY 4.0 · TH Open 2019; 03(04): e331-e334
DOI: 10.1055/s-0039-1698757
Letter to the Editor
Georg Thieme Verlag KG Stuttgart · New York

Idiopathic Renal Infarction and Anticoagulation

Maurice I. Khayat
1   Department of Nephrology, Walter Reed National Military Medical Center, Bethesda, Maryland, United States
,
Robert Nee
1   Department of Nephrology, Walter Reed National Military Medical Center, Bethesda, Maryland, United States
,
Dustin J. Little
1   Department of Nephrology, Walter Reed National Military Medical Center, Bethesda, Maryland, United States
,
Stephen W. Olson
1   Department of Nephrology, Walter Reed National Military Medical Center, Bethesda, Maryland, United States
› Author Affiliations
Further Information

Publication History

23 July 2019

27 August 2019

Publication Date:
09 October 2019 (online)

Also available ateRef
  Permissions and Reprints
Preview

Introduction

Idiopathic renal infarction (iRI) is rare and the pathophysiology is not well understood.[1] There is no consensus treatment strategy for iRI, because previous studies have not reported long-term outcomes based on therapeutic intervention.[2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] We sought to determine if anticoagulation or nonanticoagulation was associated with a higher incidence of recurrent arterial thrombosis, de novo venous thrombosis, bleeding event, or development of long-term hypertension, proteinuria, or chronic kidney disease (CKD).

Disclaimer

The views expressed in this manuscript are those of the authors and do not reflect the official policy of the Department of the Army, Department of Defense, or the U.S. government.